146 related articles for article (PubMed ID: 11084950)
21. Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate.
Trombetti A; Gerbase MW; Spiliopoulos A; Slosman DO; Nicod LP; Rizzoli R
J Heart Lung Transplant; 2000 Aug; 19(8):736-43. PubMed ID: 10967266
[TBL] [Abstract][Full Text] [Related]
22. Failure of estrogens and androgens to inhibit bone resorption in tissue culture.
Caputo CB; Meadows D; Raisz LG
Endocrinology; 1976 Apr; 98(4):1065-8. PubMed ID: 945150
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of fracture and related factors in patients with rheumatoid arthritis.
Nampei A; Hashimoto J; Koyanagi J; Ono T; Hashimoto H; Tsumaki N; Tomita T; Sugamoto K; Nishimoto N; Ochi T; Yoshikawa H
Mod Rheumatol; 2008; 18(2):170-6. PubMed ID: 18297237
[TBL] [Abstract][Full Text] [Related]
24. Alfacalcidol versus plain vitamin D in inflammation induced bone loss.
Scharla SH; Schacht E; Lempert UG
J Rheumatol Suppl; 2005 Sep; 76():26-32. PubMed ID: 16142848
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
26. Corticosteroid osteoporosis: practical implications of recent trials.
Sambrook PN
J Bone Miner Res; 2000 Sep; 15(9):1645-9. PubMed ID: 10976984
[TBL] [Abstract][Full Text] [Related]
27. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
Lange U; Teichmann J; Müller-Ladner U; Strunk J
Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid-induced osteoporosis.
Kumar R
Curr Opin Nephrol Hypertens; 2001 Sep; 10(5):589-95. PubMed ID: 11496051
[TBL] [Abstract][Full Text] [Related]
29. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
[TBL] [Abstract][Full Text] [Related]
30. [Osteoporosis and hormone replacement therapy].
Roux C
Presse Med; 2005 Mar; 34(5):379-84. PubMed ID: 15859575
[TBL] [Abstract][Full Text] [Related]
31. Estrogens in rheumatoid arthritis; the immune system and bone.
Islander U; Jochems C; Lagerquist MK; Forsblad-d'Elia H; Carlsten H
Mol Cell Endocrinol; 2011 Mar; 335(1):14-29. PubMed ID: 20685609
[TBL] [Abstract][Full Text] [Related]
32. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
33. Bone safety of low-dose glucocorticoids in rheumatic diseases.
Saag KG
Ann N Y Acad Sci; 2014 May; 1318():55-64. PubMed ID: 24815076
[TBL] [Abstract][Full Text] [Related]
34. Preventive therapy for steroid-induced osteoporosis in interstitial lung disease.
Rizzato G
Curr Opin Pulm Med; 1998 Sep; 4(5):267-71. PubMed ID: 10813201
[TBL] [Abstract][Full Text] [Related]
35. Can we use steroid hormones to immunomodulate rheumatic diseases? Rheumatoid arthritis as an example.
Bijlsma JW
Ann N Y Acad Sci; 1999 Jun; 876():366-76; discussion 376-7. PubMed ID: 10415630
[TBL] [Abstract][Full Text] [Related]
36. Hormone therapy in rheumatic diseases.
Cutolo M
Curr Opin Rheumatol; 2010 May; 22(3):257-63. PubMed ID: 20075732
[TBL] [Abstract][Full Text] [Related]
37. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis and management of primary osteoporosis.
Bauwens SF; Drinka PJ; Boh LE
Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of osteoporosis (with the exception of hormone replacement and its derivates].
Lamy O; Mischler C; Krieg MA
Rev Med Suisse Romande; 2002 Aug; 122(8):389-93. PubMed ID: 12357732
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid-induced osteoporosis: pathogenesis and management.
Nishimura J; Ikuyama S
J Bone Miner Metab; 2000; 18(6):350-2. PubMed ID: 11052469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
